Eupraxia Pharmaceuticals Common Stock Alpha and Beta Analysis
| EPRX Stock | 3.38 0.07 2.03% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eupraxia Pharmaceuticals Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eupraxia Pharmaceuticals over a specified time horizon. Remember, high Eupraxia Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eupraxia Pharmaceuticals' market risk premium analysis include:
Beta (0.93) | Alpha 0.59 | Risk 5.39 | Sharpe Ratio 0.11 | Expected Return 0.58 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Eupraxia |
Eupraxia Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eupraxia Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eupraxia Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eupraxia Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eupraxia Pharmaceuticals' performance over market.| α | 0.59 | β | -0.93 |
Eupraxia Pharmaceuticals Return and Market Media
The median price of Eupraxia Pharmaceuticals for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 is 2.76 with a coefficient of variation of 13.32. The daily time series for the period is distributed with a sample standard deviation of 0.38, arithmetic mean of 2.85, and mean deviation of 0.34. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eupraxia Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eupraxia Pharmaceuticals' short interest history, or implied volatility extrapolated from Eupraxia Pharmaceuticals options trading.
Build Portfolio with Eupraxia Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Eupraxia Pink Sheet Analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.